(CGNX) Cognex - Overview
Stock: Vision Software, Vision Systems, Barcode Readers, Vision Accessories
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.90% |
| Yield on Cost 5y | 0.38% |
| Yield CAGR 5y | 7.32% |
| Payout Consistency | 79.2% |
| Payout Ratio | 43.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 39.1% |
| Relative Tail Risk | -12.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | -10.89 |
| Character TTM | |
|---|---|
| Beta | 1.441 |
| Beta Downside | 1.895 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.98% |
| CAGR/Max DD | -0.11 |
Description: CGNX Cognex January 08, 2026
Cognex Corporation (NASDAQ: CGNX) designs and sells machine-vision hardware and software that enable automated inspection, identification, measurement, and tracking of discrete items across manufacturing and distribution lines. Its portfolio includes the VisionPro development suite, In-Sight vision sensors, the flow-chart-based QuickBuild application builder, DataMan barcode readers, and a range of accessories such as industrial cameras, lenses, and lighting. The company serves a broad customer base-including automotive, logistics, consumer electronics, medical, semiconductor, consumer products, and food-and-beverage manufacturers-through a global network of distributors and system integrators. Founded in 1981 and headquartered in Natick, Massachusetts, Cognex operates within the Electronic Equipment & Instruments sub-industry.
Key recent metrics: FY 2023 revenue reached approximately $1.5 billion, up ~13 % year-over-year, driven by strong demand for automation in automotive assembly and e-commerce fulfillment centers. The firm maintains a gross margin near 70 % and an operating margin of ~28 %, reflecting the high-value, software-heavy nature of its offerings. A primary sector catalyst is the accelerating adoption of Industry 4.0 and robotics, which is expanding the total addressable market for machine-vision solutions at an estimated CAGR of 12 % through 2028.
For a deeper quantitative view of CGNX’s valuation and risk profile, the ValueRay platform provides a concise, data-driven dashboard worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 110.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 6.21 > 1.0 |
| NWC/Revenue: 51.63% < 20% (prev 56.87%; Δ -5.25% < -1%) |
| CFO/TA 0.11 > 3% & CFO 222.0m > Net Income 110.1m |
| Net Debt (-167.0m) to EBITDA (194.6m): -0.86 < 3 |
| Current Ratio: 3.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (169.3m) vs 12m ago -1.99% < -2% |
| Gross Margin: 67.65% > 18% (prev 0.68%; Δ 6696 % > 0.5%) |
| Asset Turnover: 47.80% > 50% (prev 42.72%; Δ 5.07% > 0%) |
| Interest Coverage Ratio: -14.45 > 6 (EBITDA TTM 194.6m / Interest Expense TTM -11.3m) |
Altman Z'' 3.60
| A: 0.25 (Total Current Assets 670.9m - Total Current Liabilities 169.3m) / Total Assets 2.00b |
| B: 0.21 (Retained Earnings 412.3m / Total Assets 2.00b) |
| C: 0.08 (EBIT TTM 163.2m / Avg Total Assets 2.03b) |
| D: 0.71 (Book Value of Equity 366.5m / Total Liabilities 513.1m) |
| Altman-Z'' Score: 3.60 = AA |
Beneish M -3.03
| DSRI: 0.97 (Receivables 171.5m/160.1m, Revenue 971.7m/881.5m) |
| GMI: 1.01 (GM 67.65% / 68.40%) |
| AQI: 0.99 (AQ_t 0.58 / AQ_t-1 0.59) |
| SGI: 1.10 (Revenue 971.7m / 881.5m) |
| TATA: -0.06 (NI 110.1m - CFO 222.0m) / TA 2.00b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of CGNX shares?
Over the past week, the price has changed by +9.37%, over one month by +9.77%, over three months by +7.40% and over the past year by +10.58%.
Is CGNX a buy, sell or hold?
- StrongBuy: 8
- Buy: 3
- Hold: 8
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the CGNX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48.1 | 13.4% |
| Analysts Target Price | 48.1 | 13.4% |
| ValueRay Target Price | 43.9 | 3.7% |
CGNX Fundamental Data Overview February 03, 2026
P/E Forward = 26.2467
P/S = 6.8577
P/B = 4.3586
P/EG = 1.85
Revenue TTM = 971.7m USD
EBIT TTM = 163.2m USD
EBITDA TTM = 194.6m USD
Long Term Debt = 78.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 10.6m USD (from shortTermDebt, last quarter)
Debt = 78.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -167.0m USD (from netDebt column, last quarter)
Enterprise Value = 6.44b USD (6.66b + Debt 78.9m - CCE 300.3m)
Interest Coverage Ratio = -14.45 (Ebit TTM 163.2m / Interest Expense TTM -11.3m)
EV/FCF = 30.13x (Enterprise Value 6.44b / FCF TTM 213.8m)
FCF Yield = 3.32% (FCF TTM 213.8m / Enterprise Value 6.44b)
FCF Margin = 22.00% (FCF TTM 213.8m / Revenue TTM 971.7m)
Net Margin = 11.33% (Net Income TTM 110.1m / Revenue TTM 971.7m)
Gross Margin = 67.65% ((Revenue TTM 971.7m - Cost of Revenue TTM 314.4m) / Revenue TTM)
Gross Margin QoQ = 67.64% (prev 67.39%)
Tobins Q-Ratio = 3.22 (Enterprise Value 6.44b / Total Assets 2.00b)
Interest Expense / Debt = 5.14% (Interest Expense 4.05m / Debt 78.9m)
Taxrate = 19.25% (25.3m / 131.5m)
NOPAT = 131.8m (EBIT 163.2m * (1 - 19.25%))
Current Ratio = 3.96 (Total Current Assets 670.9m / Total Current Liabilities 169.3m)
Debt / Equity = 0.05 (Debt 78.9m / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = -0.86 (Net Debt -167.0m / EBITDA 194.6m)
Debt / FCF = -0.78 (Net Debt -167.0m / FCF TTM 213.8m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.42% (Net Income 110.1m / Total Assets 2.00b)
RoE = 7.39% (Net Income TTM 110.1m / Total Stockholder Equity 1.49b)
RoCE = 10.41% (EBIT 163.2m / Capital Employed (Equity 1.49b + L.T.Debt 78.9m))
RoIC = 8.85% (NOPAT 131.8m / Invested Capital 1.49b)
WACC = 11.15% (E(6.66b)/V(6.74b) * Re(11.23%) + D(78.9m)/V(6.74b) * Rd(5.14%) * (1-Tc(0.19)))
Discount Rate = 11.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 63.12% ; FCFF base≈165.2m ; Y1≈135.0m ; Y5≈95.5m
Fair Price DCF = 7.64 (EV 1.11b - Net Debt -167.0m = Equity 1.28b / Shares 167.6m; r=11.15% [WACC]; 5y FCF grow -21.93% → 2.90% )
EPS Correlation: -48.20 | EPS CAGR: -55.87% | SUE: -4.0 | # QB: 0
Revenue Correlation: -7.19 | Revenue CAGR: 3.42% | SUE: 3.85 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=-0.000 | Revisions Net=+1 | Analysts=13
EPS next Year (2026-12-31): EPS=1.13 | Chg30d=-0.027 | Revisions Net=-1 | Growth EPS=+17.5% | Growth Revenue=+6.5%